Pasithea Therapeutics Corp's total assets for Q1 2025 were $14.66M, a decrease of -8.75% from the previous quarter. KTTA total liabilities were $1.68M for the fiscal quarter, a 31.06% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.